Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
38.85
+0.02 (0.05%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Septerna Employees
Septerna had 130 employees as of December 31, 2025. The number of employees increased by 55 or 73.33% compared to the previous year.
Employees
130
Change (1Y)
55
Growth (1Y)
73.33%
Revenue / Employee
$760,631
Profits / Employee
-$186,431
Market Cap
1.75B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 130 | 55 | 73.33% |
| Dec 31, 2024 | 75 | - | - |
| Sep 30, 2024 | 73 | - | - |
| Jun 30, 2024 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 767 |
| Recursion Pharmaceuticals | 600 |
| Immunocore Holdings | 524 |
| Lakefront Biotherapeutics NV | 452 |
| Intellia Therapeutics | 377 |
| Syndax Pharmaceuticals | 298 |
SEPN News
- 4 hours ago - Septerna reports Q2 EPS (29c), consensus (49c) - TheFly
- 13 hours ago - Septerna Quarterly report: Q2 2026 - Filings
- 13 hours ago - Septerna Earnings release: Q2 2026 - Filings
- 6 days ago - 3 Small-Cap Stocks Analysts Expect to Rally Big - TipRanks
- 21 days ago - 3 Small-Cap Stocks with ‘Strong Buy’ Ratings and 40%+ Upside, According to Analysts - TipRanks
- 5 weeks ago - Septerna price target raised to $43 from $35 at Truist - TheFly
- 5 weeks ago - Septerna price target lowered to $45 from $52 at Guggenheim - TheFly
- 6 weeks ago - Septerna Transcript: AGM 2026 - Transcripts